INS and metabolic syndrome: INPP4B protects against metabolic syndrome and associated disorders (Zhang et al. 2021) and EXOC4 is involved in insulin-stimulated glucose transport and is associated with type II diabetes and fasting glucose (Laramie et al. 2008).